Severe COVID‐19 disease in two pediatric oncology patients
Stokes CL, Patel PA, Sabnis HS, Mitchell SG, Yildirim IB, Pauly MG. Severe COVID‐19 disease in two pediatric oncology patients. Pediatric Blood & Cancer 2020, 67: e28432. PMID: 32779861, PMCID: PMC7361273, DOI: 10.1002/pbc.28432.Peer-Reviewed Original ResearchSevere Pediatric COVID-19 Presenting With Respiratory Failure and Severe Thrombocytopenia
Patel PA, Chandrakasan S, Mickells GE, Yildirim I, Kao CM, Bennett CM. Severe Pediatric COVID-19 Presenting With Respiratory Failure and Severe Thrombocytopenia. Pediatrics 2020, 146: e20201437. PMID: 32366611, PMCID: PMC7329259, DOI: 10.1542/peds.2020-1437.Peer-Reviewed Original ResearchConceptsSevere acute respiratory distress syndromeSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Respiratory syndrome coronavirus 2Syndrome coronavirus 2Coronavirus disease 2019Respiratory failureSevere thrombocytopeniaCoronavirus 2Disease 2019Pediatric coronavirus disease 2019Airway pressure release ventilationAcute respiratory distress syndromeBroad antiviral agentPediatric COVID-19Respiratory distress syndromeUnderlying medical conditionsPast medical historySignificant clinical benefitIntravenous immunoglobulinElevated markersClinical courseDistress syndromePrompt improvementSevere morbidityThe VACCINES Act: Deciphering Vaccine Hesitancy in the Time of COVID-19
McAteer J, Yildirim I, Chahroudi A. The VACCINES Act: Deciphering Vaccine Hesitancy in the Time of COVID-19. Clinical Infectious Diseases 2020, 71: 703-705. PMID: 32282038, PMCID: PMC7184475, DOI: 10.1093/cid/ciaa433.Peer-Reviewed Original ResearchConceptsSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Respiratory syndrome coronavirus 2Syndrome coronavirus 2Vaccines actCoronavirus 2Clinical trialsVaccine hesitancyVaccine candidatesNovel vaccinesCOVID-19COVID-19 pandemicVaccineTimes of COVID19PandemicTrials